# A Study to Investigate the Effect of Gradual Titration to Optimize Cannabidiol Treatment in Adults With LGS

> **NCT07728097** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Jazz Pharmaceuticals** · enrollment: 40 (estimated)

## Conditions studied

- Lennox-Gastaut Syndrome

## Interventions

- **DRUG:** Cannabidiol Oral Solution

## Key facts

- **NCT ID:** NCT07728097
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-11-18
- **Primary completion:** 2028-12-28
- **Final completion:** 2028-12-28
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-09-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07728097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07728097, "A Study to Investigate the Effect of Gradual Titration to Optimize Cannabidiol Treatment in Adults With LGS". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07728097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*